What changed
📄 LANTERN PHARMA INC.
Lantern Pharma Inc. is a clinical-stage biotechnology company focused on using artificial intelligence, machine learning, and genomic data to streamline the drug development process. The company aims to identify, rescue, or develop abandoned or failed drug candidates, thereby reducing the time and cost associated with bringing therapies to market. Its initial focus is on developing targeted therapies for various cancers.
Offering: $30,556,650 at $30,556,650 valuation
Why it matters
Lantern Pharma Inc. is a clinical-stage biotechnology company focused on using artificial intelligence, machine learning, and genomic data to streamline the drug development process. The company aims to identify, rescue, or develop abandoned or failed drug candidates, thereby reducing the time and cost associated with bringing therapies to market. Its initial focus is on developing targeted therapies for various cancers.